Director, Biologics Analytical Development R&D
AbbVie
Summary
The Biologics Analytical R&D (ARD) group supports innovative and unique early-stage biologics pipeline which includes mAbs, Bi- and multi-specifics, antibody drug conjugates (ADCs), Antibody Oligonucleotide Conjugates (AOCs), tLNPs, peptides and other biologic medicines. The team develops analytical methodologies and provides support to drug substance and drug product process and formulation development for traditional, high concentration, and complex formulations. Biologics ARD partners with all functions across Biologics CMC to deliver high-quality drug products for patients.
Job description
The Director, Biologics ARD will lead an Analytical Development Early Phase group within AbbVie's Lake County (North Chicago headquarters) site. He/she will have accountability for multiple pipeline projects, development of relevant science and technology, people management, and implementation of functional strategies. He/she will ensure that the team's deliverables are completed within established timelines, budgets, resource allocation and in accordance with regulatory, quality, and safety requirements.
The Ideal Candidate Will
- Use a breadth of experience to drive phase-appropriate analytical development strategies to support AbbVie's early phase pipeline through leadership and scientific expertise for the Early Phase group in Analytical Development.
- Responsibility and oversight of team-led analytical method development, validation, and transfer in line with global strategies.
- Drive alignment for early-phase biologics development across Biologics Analytical R&D and partner with department subfunctions to meet the Early Biologics Excellence milestones.
- Advance early-phase analytical development concepts fit for purpose to the growing and diversifying discovery biologics portfolio.
- Effectively manage organizational interfaces (Discovery, Synthetic Molecule CMC, Biologics CMC, CMC RA, PDS&T, Operations and QA).
Responsibilities
- Accountable for early analytical method development, validation and quality control activities, technology transfers to internal and external labs and ensuring appropriate control strategies from candidate screening through Phase 1 and Phase 2 clinical studies.
- Ensures generation of ARD IND chapters for associated programs.
- Ensures alignment of analytical development concepts with Early Biologics Excellence playbook and contributes to the continued improvement of analytical acceleration levers.
- Partners with Development Science functions to select appropriate biologic candidates for development and to continuously improve the Biologics Screening Funnel requirements.
- Provide leadership and talent development for a team of 20+ analytical scientists, analytical leads and people leaders in Early Phase Analytical Development.
- Adapt to changing environments and balances priorities within Biologics Analytical R&D and ensures utilization of appropriately science-based approaches to ensure project and internal/external budget success and increase efficiency.
- Drive technological innovation and guide improvements to leverage scientific and operational excellence within Biologics Analytical R&D and in line with the Biologics CMC Development/AbbVie strategy for NBEs.
- Recruit, promote, and retain top talents via coaching and mentoring and assures effective succession planning.
- Promotes entrepreneurial thinking and makes smart business decisions while balancing risk.
- Proactively leads interfaces with other functions inside and outside of Biologics CMC Development and R&D.
- Assures compliance with AbbVie safety, quality and regulatory policies and government regulations.
- Ensures adequate support of multiple assigned CMC projects and contributes to project prioritization on a portfolio level.
- Proactively supports Biologics CMC Development Management of plans and risks through regular communications and periodic reviews throughout clinical development.
Qualifications
- BS (18+ years); MS (16+ years) or PhD (10+ years) in Chemistry, Chemical Engineering, Biochemistry, or Biology with 8+ years of previous work experience in a laboratory setting.
- Previous supervisory experience required (4+ years).
- Proven experience in leading an analytical development team within a pharmaceutical development organization across scientific disciplines, preferably with experience in biologics or related modalities.
- Strong technical knowledge from early to late stage biopharmaceutical development including manufacturing of biologic products and other parenterals.
- Experience in bioanalytical methodology (SEC, CEX, CE-SDS, icIEF, KF, UV-Vis, etc.).
- Experience in analytical characterization for biologics using LC-MS and other advanced technologies is preferred.
- Statistical knowledge and experience are preferred, e.g. capability analysis, design of experiments (DOE) methodologies.
- Experience in ELN preferred.
- Understands the various scientific disciplines needed in pharmaceutical development of biologics drug product (analytical, manufacturing, QA, supply chain, regulatory, etc.).
- Negotiation, conflict management, strong communication skills in fast moving environment.
- Evidence of multiple successful drug product leadership experiences at different stages of clinical development.
- Possesses negotiating, influencing, leadership skills.
- Creative in implementing entrepreneurial thinking and making smart business decisions.
Requirements
- BS (18+ years); MS (16+ years) or PhD (10+ years) in Chemistry, Chemical Engineering, Biochemistry, or Biology
- 8+ years of previous work experience in a laboratory setting
- Previous supervisory experience required (4+ years)
- Proven experience in leading an analytical development team within a pharmaceutical development organization across scientific disciplines
- Strong technical knowledge from early to late stage biopharmaceutical development including manufacturing of biologic products and other parenterals
- Experience in bioanalytical methodology (SEC, CEX, CE-SDS, icIEF, KF, UV-Vis, etc.)
- Experience in analytical characterization for biologics using LC-MS and other advanced technologies is preferred
- Statistical knowledge and experience are preferred, e.g. capability analysis, design of experiments (DOE) methodologies
- Experience in ELN preferred
- Understands the various scientific disciplines needed in pharmaceutical development of biologics drug product (analytical, manufacturing, QA, supply chain, regulatory, etc.)
- Negotiation, conflict management, strong communication skills in fast moving environment
- Evidence of multiple successful drug product leadership experiences at different stages of clinical development
- Possesses negotiating, influencing, leadership skills
- Creative in implementing entrepreneurial thinking and making smart business decisions
Benefits
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.